UM
CVS icon

UniSuper Management’s CVS Health CVS Stock Holding History

UniSuper Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Buy
139,963
+38,294
+38% +$3.42M 0.07% 152
2026
Q1 		$7.3M Buy
101,669
+230
+0.2% +$17.7K 0.05% 193
2025
Q4 		$8.05M Sell
101,439
-16,402
-14% -$1.29M 0.05% 182
2025
Q3 		$8.88M Buy
117,841
+29,521
+33% +$2.02M 0.05% 185
2025
Q2 		$6.09M Sell
88,320
-1,877
-2% -$123K 0.04% 208
2025
Q1 		$6.11M Sell
90,197
-1,480
-2% -$88.6K 0.05% 195
2024
Q4 		$4.12M Buy
91,677
+19,203
+26% +$1.08M 0.03% 259
2024
Q3 		$4.56M Sell
72,474
-2,453
-3% -$143K 0.03% 245
2024
Q2 		$4.43M Buy
74,927
+45,080
+151% +$2.82M 0.04% 228
2024
Q1 		$2.38M Sell
29,847
-103,566
-78% -$7.91M 0.02% 229
2023
Q4 		$10.5M Sell
133,413
-9,174
-6% -$653K 0.12% 132
2023
Q3 		$9.96M Sell
142,587
-2,193
-2% -$155K 0.12% 125
2023
Q2 		$10M Buy
+144,780
New +$10.3M 0.11% 133

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

UniSuper Management's CVS Position: Q2 2026 in Review

UniSuper Management increased its CVS Health (CVS) stake by 38% in Q2 2026, buying an estimated $3.42M and bringing the position to 139,963 shares worth $14.5M. The position accounts for 0.07% of the portfolio, ranked #152.

UniSuper Management first reported a position in CVS in Q2 2023 and has held it in 13 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • UniSuper Management held 139,963 shares of CVS Health worth $14.5M as of Q2 2026.
  • UniSuper Management bought 38,294 CVS Health shares in Q2 2026, an estimated $3.42M.
  • CVS Health made up 0.07% of UniSuper Management's portfolio in Q2 2026, its #152 holding.
  • UniSuper Management first reported a position in CVS Health in Q2 2023 and has held it in 13 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.